Literature DB >> 8800128

Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease.

A Sagie1, N Freitas, L R Padial, M Leavitt, E Morris, A E Weyman, R A Levine.   

Abstract

OBJECTIVES: The purpose of this study was to determine, in a large referral population, the rate of echocardiographic change in mitral valve area (MVA) without interim intervention, to determine which factors influence progression of narrowing and to examine associated changes in the right side of the heart.
BACKGROUND: Little information is currently available on the echocardiographic progression of mitral stenosis, particularly on progressive changes in the right side of the heart and the ability of a previously proposed algorithm to predict progression.
METHODS: We studied 103 patients (mean age 61 years; 74% female) with serial two-dimensional and Doppler echocardiography. The average interval between entry and most recent follow-up study was 3.3 +/- 2 years (range 1 to 11).
RESULTS: During the follow-up period, MVA decreased at a mean rate of 0.09 cm2/year. In 28 patients there was no decrease, in 40 there was only relatively little change (< 0.1 cm2/year) and in 35 the rate of progression of mitral valve narrowing was more rapid (> or = 0.1 cm2/year). The rate of progression was significantly greater among patients with a larger initial MVA and milder mitral stenosis (0.12 vs. 0.06 vs. 0.03 cm2/year for mild, moderate and severe stenosis, p < 0.01). Although the rate of mitral valve narrowing was a weak function of initial MVA and echocardiographic score by multivariate analysis, no set of individual values or cutoff points of these variables or pressure gradients could predict this rate in individual patients. There was a significant increase in right ventricular diastolic area (17 to 18.7 cm2) and tricuspid regurgitation grade (2 + to 3 +; p < 0.0001 between entry and follow-up studies). Progression in right heart disease occurred even in patients with minimal or no change in MVA. Patients with associated aortic regurgitation had a higher rate of decrease in MVA than did those with trace or no aortic regurgitation (0.19 vs. 0.086 cm2/year, p < 0.05).
CONCLUSIONS: The rate of mitral valve narrowing in individual patients is variable and cannot be predicted by initial MVA, mitral valve score or transmitral gradient, alone or in combination. Right heart disease can progress independent of mitral valve narrowing.

Entities:  

Mesh:

Year:  1996        PMID: 8800128     DOI: 10.1016/0735-1097(96)00153-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve disease.

Authors:  Francesco Antonini-Canterin; Luis M Moura; Roxana Enache; Elisa Leiballi; Daniela Pavan; Rita Piazza; Bogdan A Popescu; Carmen Ginghina; Gian Luigi Nicolosi; Nalini M Rajamannan
Journal:  Circulation       Date:  2010-05-03       Impact factor: 29.690

2.  Assessment of right ventricular strain and strain rate in patients with severe mitral stenosis before and after balloon mitral valvuloplasty.

Authors:  Vipin Kumar; V Jacob Jose; Purendra Kumar Pati; John Jose
Journal:  Indian Heart J       Date:  2014-03-01

3.  Impact of net atrioventricular compliance on clinical outcome in mitral stenosis.

Authors:  Maria Carmo P Nunes; Judy Hung; Marcia M Barbosa; William A Esteves; Vinicius T Carvalho; Lucas Lodi-Junqueira; Cirilo P Fonseca Neto; Timothy C Tan; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-04       Impact factor: 7.792

Review 4.  Pathophysiology and management of multivalvular disease.

Authors:  Philippe Unger; Marie-Annick Clavel; Brian R Lindman; Patrick Mathieu; Philippe Pibarot
Journal:  Nat Rev Cardiol       Date:  2016-04-28       Impact factor: 32.419

Review 5.  Endovascular Therapy for Rheumatic Mitral and Aortic Valve Disease: Review Article.

Authors:  Tesfaye Telila; Elsayed Mohamed; Kurt M Jacobson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-22

6.  Low-Gradient Severe Mitral Stenosis: Hemodynamic Profiles, Clinical Characteristics, and Outcomes.

Authors:  Abdallah El Sabbagh; Yogesh N V Reddy; Sergio Barros-Gomes; Barry A Borlaug; William R Miranda; Sorin V Pislaru; Rick A Nishimura; Patricia A Pellikka
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

7.  Identification of Distinct Subgroups in Moderately Severe Rheumatic Mitral Stenosis Using Data-Driven Phenotyping of Longitudinal Hemodynamic Progression.

Authors:  Kyu-Yong Ko; Iksung Cho; Subin Kim; Yeonchan Seong; Dae-Young Kim; Ji Won Seo; Seng Chan You; Chi Young Shim; Geu-Ru Hong; Jong-Won Ha
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

8.  Rheumatic mitral stenosis in children: more accelerated course in sub-Saharan patients.

Authors:  Henok Tadele; Wubegzier Mekonnen; Endale Tefera
Journal:  BMC Cardiovasc Disord       Date:  2013-11-01       Impact factor: 2.298

9.  Use of strain and strain rate echocardiographic imaging to predict the progression of mitral stenosis: a 5-year follow-up study the progression of mitral stenosis: a 5-year follow-up study.

Authors:  Demet Menekşe Gerede; Aydan Ongun; Cansın Tulunay Kaya; Aynur Acıbuca; Nil Özyüncü; Çetin Erol
Journal:  Anatol J Cardiol       Date:  2016-02-04       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.